Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06206096
Status:
RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-01-04
Brief Title:
PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC
Sponsor:
Chinese PLA General Hospital
Organization:
Chinese PLA General Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Microsatellite Stable Colorectal Carcinoma |
| Colorectal Cancer |
| RAS Mutation |
| Colorectal Neoplasms |
Keywords: